WHO Collaboration
We are thrilled to announce that at the 156th WHO Executive Board Meeting in February 2025, IFBLS received approval to continue as a Non-State Actor in Official Relations with the World Health Organization (WHO) for another three years.
This achievement reflects the strength of our ongoing partnership and the extensive collaboration that went into developing the IFBLS-WHO Triennial Workplan for 2025–2027. We are especially pleased to be working closely with Dr. Ana Aceves Capri, Technical Officer at the WHO in Geneva, Switzerland, as we advance our shared goals in global health.
We look forward to a productive and impactful collaboration in the years ahead!
Statements:
To see the statement submitted by IFBLS to the WHO Special session of the Executive Board in October 2020 click below:
To see the statement submitted by IFBLS to the 146th WHO Executive Board in February 2020 click below:
- IFBLS Statement on Accelerating Cervical Cancer Elimination 146th WHO Executive Board February 2020
IFBLS Oral Statement on Accelerating Cervical Cancer Elimination 146th WHO Executive Board February 2020
To see the statement submitted by IFBLS to the 73rd World Health Assembly in May 2020 click below:
To see the statements submitted by IFBLS to the 144th WHO Executive Board in January 2019 click below:
- IFBLS Statement on Accelerating Cervical Cancer Elimination 144th WHO Executive Board January 2019
- IFBLS Statement on Antimicrobial Resistance 144th WHO Executive Board January 2019
- IFBLS Statement on Human Resources for Health 144th WHO Executive Board January 2019
- IFBLS Statement on Non-Communicable Diseases 144th WHO Executive Board January 2019
- To see the video statement delivered by President-Elect Alan Wainwright on the Prevention and Control of Non-Communicable Diseases at the 144th WHO Executive Board in January 2019 click here.
